LOUISVILLE SURGEONS PLAN UPDATE
ON STATUS OF FIRST ABIOCOR PATIENT
(LOUISVILLE) - The University of Louisville surgeons
who implanted the world's first totally implantable replacement
heart in Bob Tools at Jewish Hospital on July 2 announced today
that they will update the public on Mr. Tools' condition on Wednesday,
November 14 at 2:00 p.m. EST.
Dr. Laman Gray reported a major setback for Mr. Tools,
which "began with the onset of weakness in the right side of
Additional details regarding the patients enrolled
in the Jewish Hospital/University of Louisville AbioCor clinical
trial will not be available until the news briefing.
Dr. Gray and Dr. Robert Dowling will give a full update
on Mr. Tools' current diagnosis and prognosis tomorrow at 2:00 p.m.
EST in the Conference Center atop the Rudd Heart and Lung Center
on the Jewish Hospital campus.
The news conference will be up-linked live via satellite
coordinates Ku-Band SBS 6, Transponder 7, Horizontal Frequency 11872
MHZ, 74 degrees West. The audio frequency is 6.20/6.80. The signal
will be available from 2-3 p.m. (EST), Wednesday, November 14.
The news conference will also be web cast at
www.heartpioneers.com. For future reference, the press conference
will be archived on www.heartpioneers.com.
Acrobat Reader Required)